N. Borg et al., DISTRIBUTION TO THE BRAIN AND PROTEIN-BINDING OF 3'-SUBSTITUTED AND 5-SUBSTITUTED 2',3'-DIDEOXYURIDINE DERIVATIVES, STUDIED BY MICRODIALYSIS, Antiviral chemistry & chemotherapy, 8(1), 1997, pp. 47-53
The aim of this study was to investigate a series of 3' and 5-substitu
ted 2',3'-dideoxyuridine derivatives (ddUD) with respect to plasma pro
tein binding, half-life and distribution across the blood-brain barrie
r in the rat. The microdialysis technique was used to study protein bi
nding in human plasma (in vitro), and to sample the extracellular spac
e of rats with microdialysis probes implanted into the striatum of the
brain and the gastrocnemic muscle (in vivo). The compounds were analy
sed by HPLC with UV-detection. The octanol/water partition coefficient
s of the ddUD varied from 0.08-0.84. The protein binding of the ddUDs
was approximately 80%. After s.c. administration (25 or 50 mg kg(-1)),
the brain and muscle extracellular levels differed; brain levels were
0.18-0.36 of peripheral (muscle) concentrations. A multivariate analy
sis, which included data on zidovudine, alovudine and thymidine, demon
strated a relationship between the physicochemical and some of the pha
rmacokinetic properties of uridine analogues. The analysis shows that
half-life and protein binding increases with decreasing pK(a). However
, penetration to the brain is not correlated with the partition into o
ctanol. it is concluded that the transport to the brain is not primari
ly dependent upon passive diffusion over a lipophilic barrier but, rat
her, to other chemical properties of the ddUDs. This is suggestive of
a specific transport mechanism, e.g. the thymidine carrier.